{"title":"Erratum: Patient-Reported Outcomes Improve Following Mastectomy for Early-Stage Breast Cancer in Nigeria: Pilot Experience Using a Translated and Validated BREAST-Q.","authors":"","doi":"10.1200/GO-24-00369","DOIUrl":"https://doi.org/10.1200/GO-24-00369","url":null,"abstract":"","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Magdalene Eno Effiong, Israel Sunmola Afolabi, Shalom Nwodo Chinedu
Purpose: Breast cancer (BC) is a major cause of cancer-related mortality in Nigeria, which is exacerbated by a lack of understanding of how knowledge of BC risk factors influences the lifestyle and dietary patterns of Nigerians across age groups. This study evaluated the influence of knowledge of BC risks on lifestyle and dietary patterns across age groups, aiming to inform early management, prevention, and survival rates.
Methods: A cross-sectional survey was conducted in Ota, Ado-odo, Ogun State, Nigeria, involving participants from six educational institutions. The study assessed knowledge of BC risks factors and lifestyle/dietary habits using questionnaires. Results were analyzed using Epi Info software and SPSS version 20.
Results: The participants' age ranged from 13 to 60 years, with a mean of 21 years. The age categories of the participants were 75.24% adolescents (13-19), 18.68% young adults (20-40), and 6.08% middle-aged (41-60). Middle-aged individuals had the least knowledge about smoking (7.58%), alcohol (26.09%), antibiotics (7.25%), and red meat/smoked foods (20.09%), which translated into their poor dietary/lifestyle patterns. Young adults showed profound physical inactivity (71.00%), while adolescents consumed more carbonated drinks (71.53%), which corresponded to lack of knowledge about the effects of physical inactivity (10.85%) and consumption of carbonated drinks (13.70%) on BC risk.
Conclusion: The study found that understanding BC risk factors directly affects lifestyle and dietary patterns. Age groups with higher knowledge had better lifestyle/dietary patterns. This highlights the need for a tailored intervention on lifestyle and dietary education across all age groups, especially the middle-aged, so as to inform a deliberate adjustment in lifestyle and dietary habits, which play crucial roles in BC incidence, survival, and prevention.
{"title":"Age-Stratified Assessment of the Impact of Breast Cancer Knowledge on the Lifestyle and Dietary Patterns Among Nigerian Females.","authors":"Magdalene Eno Effiong, Israel Sunmola Afolabi, Shalom Nwodo Chinedu","doi":"10.1200/GO.24.00178","DOIUrl":"10.1200/GO.24.00178","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer (BC) is a major cause of cancer-related mortality in Nigeria, which is exacerbated by a lack of understanding of how knowledge of BC risk factors influences the lifestyle and dietary patterns of Nigerians across age groups. This study evaluated the influence of knowledge of BC risks on lifestyle and dietary patterns across age groups, aiming to inform early management, prevention, and survival rates.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted in Ota, Ado-odo, Ogun State, Nigeria, involving participants from six educational institutions. The study assessed knowledge of BC risks factors and lifestyle/dietary habits using questionnaires. Results were analyzed using Epi Info software and SPSS version 20.</p><p><strong>Results: </strong>The participants' age ranged from 13 to 60 years, with a mean of 21 years. The age categories of the participants were 75.24% adolescents (13-19), 18.68% young adults (20-40), and 6.08% middle-aged (41-60). Middle-aged individuals had the least knowledge about smoking (7.58%), alcohol (26.09%), antibiotics (7.25%), and red meat/smoked foods (20.09%), which translated into their poor dietary/lifestyle patterns. Young adults showed profound physical inactivity (71.00%), while adolescents consumed more carbonated drinks (71.53%), which corresponded to lack of knowledge about the effects of physical inactivity (10.85%) and consumption of carbonated drinks (13.70%) on BC risk.</p><p><strong>Conclusion: </strong>The study found that understanding BC risk factors directly affects lifestyle and dietary patterns. Age groups with higher knowledge had better lifestyle/dietary patterns. This highlights the need for a tailored intervention on lifestyle and dietary education across all age groups, especially the middle-aged, so as to inform a deliberate adjustment in lifestyle and dietary habits, which play crucial roles in BC incidence, survival, and prevention.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael P Dykstra, Katrin S Sadigh, Isaac Nkele, Memory Bvochora-Nsingo, Yehoda M Martei, James Wester, Kutlo Manyake, Jason A Efstathiou, Peter Vuylsteke, Neo M Tapela, Scott Dryden-Peterson
Purpose: Women living with HIV (WLWH) experience decreased breast cancer survival. We sought to determine whether WLWH surviving breast cancer also experienced different quality of life (QOL) gain.
Methods: Women who enrolled in the Thabatse Cancer Cohort across oncology centers in Botswana for the initial treatment of stage I-III breast cancer from October 2010 to February 2022 were included. Exclusion criteria were no documented definitive therapy and incomplete data at treatment end or 24 ± 3 months after treatment. QOL was measured quarterly using the SF-8 questionnaire. G methods using weighted exposure and outcome modules were used to mitigate potential bias from imbalances in demographic and cancer characteristics by HIV status. Primary analysis was change in physical component summary (PCS) and mental component summary (MCS) from treatment end to 24 months after treatment for WLWH compared with women without HIV.
Results: Of 603 women enrolled, the final analysis included 298, comprising 85 WLWH and 213 women without HIV. Most common reasons for exclusion were no documented definitive treatment (n = 114) and death before 21 months after treatment (n = 137). WLWH were younger, were less wealthy, and had more estrogen receptor/progesterone receptor positive tumors. Overall, PCS and MCS significantly increased from treatment end to 24 months after treatment, from 50.8 to 52.8 and 51.8 to 53.7, respectively. There was no difference in the change of the PCS or MCS with HIV infection, 2.2 (95% CI, -0.4 to 4.9) and 0.6 (95% CI, -1.7 to 2.9), respectively.
Conclusion: HIV infection did not impede QOL gain at 24 months after treatment in women surviving breast cancer. Further work is needed to clarify the role of HIV on specific treatment-related morbidities and in other malignancies.
{"title":"Quality of Life Gain Following Treatment Among Breast Cancer Survivors With and Without HIV.","authors":"Michael P Dykstra, Katrin S Sadigh, Isaac Nkele, Memory Bvochora-Nsingo, Yehoda M Martei, James Wester, Kutlo Manyake, Jason A Efstathiou, Peter Vuylsteke, Neo M Tapela, Scott Dryden-Peterson","doi":"10.1200/GO.24.00110","DOIUrl":"10.1200/GO.24.00110","url":null,"abstract":"<p><strong>Purpose: </strong>Women living with HIV (WLWH) experience decreased breast cancer survival. We sought to determine whether WLWH surviving breast cancer also experienced different quality of life (QOL) gain.</p><p><strong>Methods: </strong>Women who enrolled in the Thabatse Cancer Cohort across oncology centers in Botswana for the initial treatment of stage I-III breast cancer from October 2010 to February 2022 were included. Exclusion criteria were no documented definitive therapy and incomplete data at treatment end or 24 ± 3 months after treatment. QOL was measured quarterly using the SF-8 questionnaire. G methods using weighted exposure and outcome modules were used to mitigate potential bias from imbalances in demographic and cancer characteristics by HIV status. Primary analysis was change in physical component summary (PCS) and mental component summary (MCS) from treatment end to 24 months after treatment for WLWH compared with women without HIV.</p><p><strong>Results: </strong>Of 603 women enrolled, the final analysis included 298, comprising 85 WLWH and 213 women without HIV. Most common reasons for exclusion were no documented definitive treatment (n = 114) and death before 21 months after treatment (n = 137). WLWH were younger, were less wealthy, and had more estrogen receptor/progesterone receptor positive tumors. Overall, PCS and MCS significantly increased from treatment end to 24 months after treatment, from 50.8 to 52.8 and 51.8 to 53.7, respectively. There was no difference in the change of the PCS or MCS with HIV infection, 2.2 (95% CI, -0.4 to 4.9) and 0.6 (95% CI, -1.7 to 2.9), respectively.</p><p><strong>Conclusion: </strong>HIV infection did not impede QOL gain at 24 months after treatment in women surviving breast cancer. Further work is needed to clarify the role of HIV on specific treatment-related morbidities and in other malignancies.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Faryal M Raza, Elifuraha W Mkwizu, Steven A Leak, Abid M Sadiq, Furaha S Lyamuya, Nyasatu G Chamba, Kajiru G Kilonzo, Elichilia R Shao, Eijaaz A Ahmed, Eliasa K Ndale, Andrew R Costantine, Eugenie M Kamabu, Doreen T Eliah, Eliada B Nziku, Oliver Henke
Purpose: This study sought to delineate the clinical, laboratory, and imaging characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities administered, and ascertain the survival rates among patients with MM over a comprehensive 5-year span in Tanzania.
Methods: This retrospective cohort study investigated patients diagnosed with MM at the Cancer Care Clinic, Kilimanjaro Christian Medical Centre, between January 2017 and June 2022. Demographic data, clinical profiles, and survival outcomes were collected. The study employed the Kaplan-Meier method to determine overall survival (OS) and survival rates, supported by univariate analysis and a multivariate Cox regression model with significance of P < .05.
Results: In this study of 76 patients with MM, bone pain was the most common complaint (76.3%), and patients were age typically older than 50 years (82.5%). Laboratory tests showed frequent abnormalities, such as anemia (51.3%) and hypercalcemia (23.9%). Most patients were at stage III according to Durie Salmon Staging (82.7%), with imaging revealing various bone abnormalities. The median OS was 18.0 months, with 46.1% of patients passing away during the study period. Factors linked to shorter survival included anemia, renal failure, and bone involvement. Infection was the primary cause of death among these patients. The presenting complaint of bone pain significantly affected survival outcomes.
Conclusion: This study provides a comprehensive understanding of MM within the Sub-Saharan African context, highlighting age-related disparities in diagnosis, predominant presenting symptoms like bone pain, factors contributing to delayed diagnoses, and the impact on survival rates. The findings underscore the critical need for early recognition, improved diagnostics, and tailored interventions to enhance outcomes for patients with MM in this region.
目的:本研究旨在描述坦桑尼亚多发性骨髓瘤(MM)诊断过程中的临床、实验室和影像学特征,概述所采用的治疗方法,并确定MM患者5年的生存率:这项回顾性队列研究调查了2017年1月至2022年6月期间在乞力马扎罗基督教医疗中心癌症护理诊所确诊的多发性骨髓瘤患者。研究收集了人口统计学数据、临床概况和生存结果。研究采用Kaplan-Meier法确定总生存期(OS)和生存率,并辅以单变量分析和多变量Cox回归模型,显著性P<.05:在这项对 76 名 MM 患者进行的研究中,骨痛是最常见的主诉(76.3%),患者的年龄一般在 50 岁以上(82.5%)。实验室检查经常出现异常现象,如贫血(51.3%)和高钙血症(23.9%)。根据 Durie Salmon 分期法,大多数患者处于 III 期(82.7%),影像学检查显示有各种骨质异常。中位生存期为18.0个月,46.1%的患者在研究期间去世。导致生存期缩短的因素包括贫血、肾功能衰竭和骨受累。感染是这些患者死亡的主要原因。骨痛的主诉对生存结果有很大影响:本研究提供了对撒哈拉以南非洲地区 MM 的全面了解,强调了与年龄相关的诊断差异、骨痛等主要表现症状、导致诊断延迟的因素以及对生存率的影响。研究结果突出表明,该地区亟需早期识别、改进诊断和有针对性的干预措施,以提高 MM 患者的治疗效果。
{"title":"Factors Associated With Survival Among Patients With Multiple Myeloma in Northeastern Tanzania.","authors":"Faryal M Raza, Elifuraha W Mkwizu, Steven A Leak, Abid M Sadiq, Furaha S Lyamuya, Nyasatu G Chamba, Kajiru G Kilonzo, Elichilia R Shao, Eijaaz A Ahmed, Eliasa K Ndale, Andrew R Costantine, Eugenie M Kamabu, Doreen T Eliah, Eliada B Nziku, Oliver Henke","doi":"10.1200/GO.24.00033","DOIUrl":"https://doi.org/10.1200/GO.24.00033","url":null,"abstract":"<p><strong>Purpose: </strong>This study sought to delineate the clinical, laboratory, and imaging characteristics during multiple myeloma (MM) diagnosis, outline the treatment modalities administered, and ascertain the survival rates among patients with MM over a comprehensive 5-year span in Tanzania.</p><p><strong>Methods: </strong>This retrospective cohort study investigated patients diagnosed with MM at the Cancer Care Clinic, Kilimanjaro Christian Medical Centre, between January 2017 and June 2022. Demographic data, clinical profiles, and survival outcomes were collected. The study employed the Kaplan-Meier method to determine overall survival (OS) and survival rates, supported by univariate analysis and a multivariate Cox regression model with significance of <i>P</i> < .05.</p><p><strong>Results: </strong>In this study of 76 patients with MM, bone pain was the most common complaint (76.3%), and patients were age typically older than 50 years (82.5%). Laboratory tests showed frequent abnormalities, such as anemia (51.3%) and hypercalcemia (23.9%). Most patients were at stage III according to Durie Salmon Staging (82.7%), with imaging revealing various bone abnormalities. The median OS was 18.0 months, with 46.1% of patients passing away during the study period. Factors linked to shorter survival included anemia, renal failure, and bone involvement. Infection was the primary cause of death among these patients. The presenting complaint of bone pain significantly affected survival outcomes.</p><p><strong>Conclusion: </strong>This study provides a comprehensive understanding of MM within the Sub-Saharan African context, highlighting age-related disparities in diagnosis, predominant presenting symptoms like bone pain, factors contributing to delayed diagnoses, and the impact on survival rates. The findings underscore the critical need for early recognition, improved diagnostics, and tailored interventions to enhance outcomes for patients with MM in this region.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rod Carlo Columbres, Erin Jay G Feliciano, Lance Isidore Catedral, Jose Ma H Zaldarriaga, Michelle Ann B Eala, Jerickson Abbie Flores, Enrico D Tangco, Narjust Florez, Frederic Ivan L Ting, Edward Christopher Dee
{"title":"Financial Sequelae of Cancer for Patients' Family Members and Caregivers: A Focus on the Philippines.","authors":"Rod Carlo Columbres, Erin Jay G Feliciano, Lance Isidore Catedral, Jose Ma H Zaldarriaga, Michelle Ann B Eala, Jerickson Abbie Flores, Enrico D Tangco, Narjust Florez, Frederic Ivan L Ting, Edward Christopher Dee","doi":"10.1200/GO.24.00074","DOIUrl":"https://doi.org/10.1200/GO.24.00074","url":null,"abstract":"","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141590344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Iman Ahmed, Moawia M A Elhassan, Khatir Elnour, Richard Sullivan, Nazik Hammad
Sudan has been under an armed conflict between the Sudanese Armed Forces and the Rapid Support Forces (RSF) militia since April 15, 2023. The conflict has turned the country into the largest internal displacement humanitarian crisis with 9.05 million internally displaced persons including 2.2 million children younger than 5 years and caused 1.47 million Sudanese to flee the country as refugees. The conflict has had a major destructive impact on the health system, which has incurred targeting with air raids, ground invasion, vandalization, looting of assets and supplies, and killing of doctors, nurses, and other health personnel. Khartoum Oncology Hospital, Sudan's main cancer hub for treatment, diagnostics, and research has become nonfunctional as a result of the conflict. The National Cancer Institute in Wad Medani, the second largest hub, faced a similar fate as the conflict spread to Al-Gezira State. Patients with cancer have been displaced multiple times in Sudan with grave consequences on the continuity of care, worsening of their disease outcomes and palpable negative impacts on children. The oncology workforce in Sudan have themselves been displaced yet are working hard to provide services and care for patients under impossible circumstances. Sudan's doctors in diaspora have rallied to provide support but they face multiple obstacles. As the conflict continues to spread, we call upon the WHO, the United Nations Children's Fund, St Jude Hospital, and all relevant partners to implement an immediate evacuation operation with urgent air lifts of the affected children to continue their cancer care in neighboring countries as was done in Ukraine and Gaza.
{"title":"Collapse of Cancer Care Under the Current Conflict in Sudan.","authors":"Iman Ahmed, Moawia M A Elhassan, Khatir Elnour, Richard Sullivan, Nazik Hammad","doi":"10.1200/GO.24.00144","DOIUrl":"10.1200/GO.24.00144","url":null,"abstract":"<p><p>Sudan has been under an armed conflict between the Sudanese Armed Forces and the Rapid Support Forces (RSF) militia since April 15, 2023. The conflict has turned the country into the largest internal displacement humanitarian crisis with 9.05 million internally displaced persons including 2.2 million children younger than 5 years and caused 1.47 million Sudanese to flee the country as refugees. The conflict has had a major destructive impact on the health system, which has incurred targeting with air raids, ground invasion, vandalization, looting of assets and supplies, and killing of doctors, nurses, and other health personnel. Khartoum Oncology Hospital, Sudan's main cancer hub for treatment, diagnostics, and research has become nonfunctional as a result of the conflict. The National Cancer Institute in Wad Medani, the second largest hub, faced a similar fate as the conflict spread to Al-Gezira State. Patients with cancer have been displaced multiple times in Sudan with grave consequences on the continuity of care, worsening of their disease outcomes and palpable negative impacts on children. The oncology workforce in Sudan have themselves been displaced yet are working hard to provide services and care for patients under impossible circumstances. Sudan's doctors in diaspora have rallied to provide support but they face multiple obstacles. As the conflict continues to spread, we call upon the WHO, the United Nations Children's Fund, St Jude Hospital, and all relevant partners to implement an immediate evacuation operation with urgent air lifts of the affected children to continue their cancer care in neighboring countries as was done in Ukraine and Gaza.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women.
Methods: This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables.
Results: The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively.
Conclusion: This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.
{"title":"Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review.","authors":"Abdulhafiz Oladapo Adesunkanmi, Funmilola Olanike Wuraola, Oluwatobiloba Michael Fagbayimu, Murtuza Aliasger Calcuttawala, Tajudeen Wahab, Adewale Oluseye Adisa","doi":"10.1200/GO.23.00460","DOIUrl":"https://doi.org/10.1200/GO.23.00460","url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer is the most frequently diagnosed cancer in women worldwide. Surgery is a major treatment modality for breast cancer, and over the years, breast-conserving surgeries with breast radiation have shown similar outcomes with mastectomy. Not much is known about the frequency and outcome of breast-conserving surgery in Africa. This systematic review provides a comprehensive summary of the evidence evaluating cosmetic and oncologic outcomes after oncoplastic breast-conserving surgery (OBCS) for breast cancer in African women.</p><p><strong>Methods: </strong>This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases were systematically searched for studies on African women undergoing OBCS. The oncologic and cosmetic outcomes, as well as the localization and reconstruction techniques, were evaluated. Descriptive statistics were used to summarize the frequency and proportions of the extracted variables.</p><p><strong>Results: </strong>The literature search yielded 266 articles but only 26 of these were included in the review. Majority of the studies were from Egypt and South Africa. These studies collectively evaluated 1,896 patients with a mean age of 48.2 years and a mean follow-up period of 36.9 months. The most common histopathology was T2 (71.4%) invasive ductal carcinoma. Hook wire localization was the most common technique used for nonpalpable lesions in 85.3% of patients. Of the studies reporting oncoplastic technique, the latissimus dorsi volume replacement technique was the most reported (15%). Most patients were satisfied with their cosmetic outcome. Seroma was the most common postoperative complication (44.6%). Among studies that reported oncologic outcome data, the crude overall survival and disease-free survival were 93.1% and 89.4%, respectively.</p><p><strong>Conclusion: </strong>This systematic review revealed that the outcome of OBCS in African women compares with that in developed countries.</p>","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Disease progression after intensive multi modal clinical therapy poses grave concern not only on the quality of life but on the very survival of children presented with neuroblastoma. Acquired modifications of energy metabolism in the tumor cells that defy clinical therapy plays pivotal role in frequent and rapid tumor relapse. We investigated the mechanisms of how these cells adopt metabolic rearrangements with therapy pressure. Our earlier findings showed the constitutive availability of retinal degeneration protein 3 (RD3) in human fetal tissues beyond retina, displayed its functional role in tumor pathogenesis, and unearthed its significance in neuroblastoma clinical outcomes. Herein, with the gene surrogate strategy, the whole genome RNA sequencing in reverse engineered (bed-to-bench) patient derived cell lines showed a patient-independent, RD3-dependent stabilization of metabolic programming. Loss of RD3 altered crucial metabolic pathways and coordinated metabolic mayhem in high-risk stage-4 disease. Evaluating the glycolysis phenotype with seahorse revealed that RD3 loss dependent increase in extracellular acidification rate (EACR) associated with glycolysis, glycolytic capacity and glycolytic reserves in therapy defying progressive disease. Critically, therapeutic delivery of RD3 (custom archived and characterized RD3 peptide candidates) significantly deregulated glycolysis in such progressive disease that lack RD3, recognizing a RD3-dependent regulation of metabolic activity. Our study outcomes clearly portrayed the thus far unrealized significance of therapy pressure driven RD3 loss mediated metabolism deregulation in neuroblastoma. Crucially, these new findings will pave way for the identification of a novel targeted maintenance therapeutic strategy for treatment of this deadly disease.
{"title":"Metabolic Reprogramming and Extracranial Solid Tumor Evolution in Infants","authors":"Poorvi Subramanian, Natarajan Aravindan","doi":"10.1200/go-24-98000","DOIUrl":"https://doi.org/10.1200/go-24-98000","url":null,"abstract":"Disease progression after intensive multi modal clinical therapy poses grave concern not only on the quality of life but on the very survival of children presented with neuroblastoma. Acquired modifications of energy metabolism in the tumor cells that defy clinical therapy plays pivotal role in frequent and rapid tumor relapse. We investigated the mechanisms of how these cells adopt metabolic rearrangements with therapy pressure. Our earlier findings showed the constitutive availability of retinal degeneration protein 3 (RD3) in human fetal tissues beyond retina, displayed its functional role in tumor pathogenesis, and unearthed its significance in neuroblastoma clinical outcomes. Herein, with the gene surrogate strategy, the whole genome RNA sequencing in reverse engineered (bed-to-bench) patient derived cell lines showed a patient-independent, RD3-dependent stabilization of metabolic programming. Loss of RD3 altered crucial metabolic pathways and coordinated metabolic mayhem in high-risk stage-4 disease. Evaluating the glycolysis phenotype with seahorse revealed that RD3 loss dependent increase in extracellular acidification rate (EACR) associated with glycolysis, glycolytic capacity and glycolytic reserves in therapy defying progressive disease. Critically, therapeutic delivery of RD3 (custom archived and characterized RD3 peptide candidates) significantly deregulated glycolysis in such progressive disease that lack RD3, recognizing a RD3-dependent regulation of metabolic activity. Our study outcomes clearly portrayed the thus far unrealized significance of therapy pressure driven RD3 loss mediated metabolism deregulation in neuroblastoma. Crucially, these new findings will pave way for the identification of a novel targeted maintenance therapeutic strategy for treatment of this deadly disease.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141838638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Loureiro, Guihherme Ferreira Cruz, Eduarda Paica Borsa, Heitor Vieira Rodrigues, Pedro Henrique Paesi Dutra
Bladder cancer represents a significant public health concern worldwide, with its incidence and socioeconomic impact standing out as persistent challenges. The objectives of this study were to analyze deaths related to malignant bladder neoplasms in Brazil between 2019 and 2022, conducting an analysis in relation to the age group, sex, and color/race of the patients, with the aim of providing an overview of mortality during this period. This is a cross-sectional, retrospective, descriptive study about deaths related to malignant bladder neoplasms in Brazil from 2019 to 2022. The data were gathered from the Brazilian Unified Health System (DATASUS) in the “Tabnet” section, selecting those that addressed the age group, sex, and color/race of the patient. The information was grouped in the four years in question based on the three variables mentioned and subsequently analyzed to establish an overview of mortality in the period. The period and detailed age group accounted for a total of 10,073 deaths in Brazil. The highest number of deaths occurred in 2022 (26.92%), followed by 2021 (25.68%). There was an increase in total prevalence during the studied period, with the highest rate of increase between the years 2020 and 2021 (6.54%), followed by 4.83% between the years 2021-2022. Comparing 2019 with 2022, there was an increase of 15.60%, with the number of deaths in 2022 equivalent to 26.92% of the entire period studied. There were more deaths among male patients, with more than a 100% difference in prevalence between sexes throughout the entire period. The Caucasian population was the most affected, corresponding to 64.57% of deaths during this period. Therefore, it is possible to understand, based on the epidemiological profile constructed, how deaths related to malignant bladder neoplasms in adults have been established in recent years. Thus, it is noted that mortality has increased, emphasizing the relevance of the problem. It was also possible to outline the most prevalent patient profile, which corresponds to male and Caucasian patients. Therefore, the broad development of measures to mitigate this alarming public health problem becomes relevant in Brazil.
{"title":"Epidemiological Analysis of Deaths for Malignant Bladder Neoplasia in Adults in the Last 4 Years in Brazilian Territory","authors":"Y. Loureiro, Guihherme Ferreira Cruz, Eduarda Paica Borsa, Heitor Vieira Rodrigues, Pedro Henrique Paesi Dutra","doi":"10.1200/go-24-56000","DOIUrl":"https://doi.org/10.1200/go-24-56000","url":null,"abstract":"Bladder cancer represents a significant public health concern worldwide, with its incidence and socioeconomic impact standing out as persistent challenges. The objectives of this study were to analyze deaths related to malignant bladder neoplasms in Brazil between 2019 and 2022, conducting an analysis in relation to the age group, sex, and color/race of the patients, with the aim of providing an overview of mortality during this period. This is a cross-sectional, retrospective, descriptive study about deaths related to malignant bladder neoplasms in Brazil from 2019 to 2022. The data were gathered from the Brazilian Unified Health System (DATASUS) in the “Tabnet” section, selecting those that addressed the age group, sex, and color/race of the patient. The information was grouped in the four years in question based on the three variables mentioned and subsequently analyzed to establish an overview of mortality in the period. The period and detailed age group accounted for a total of 10,073 deaths in Brazil. The highest number of deaths occurred in 2022 (26.92%), followed by 2021 (25.68%). There was an increase in total prevalence during the studied period, with the highest rate of increase between the years 2020 and 2021 (6.54%), followed by 4.83% between the years 2021-2022. Comparing 2019 with 2022, there was an increase of 15.60%, with the number of deaths in 2022 equivalent to 26.92% of the entire period studied. There were more deaths among male patients, with more than a 100% difference in prevalence between sexes throughout the entire period. The Caucasian population was the most affected, corresponding to 64.57% of deaths during this period. Therefore, it is possible to understand, based on the epidemiological profile constructed, how deaths related to malignant bladder neoplasms in adults have been established in recent years. Thus, it is noted that mortality has increased, emphasizing the relevance of the problem. It was also possible to outline the most prevalent patient profile, which corresponds to male and Caucasian patients. Therefore, the broad development of measures to mitigate this alarming public health problem becomes relevant in Brazil.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. T. Deressa, Haji Aman Deybasso, Abebe Megerso, Jibril Bashir Adem, Dagim Tekeba, M. Mama, Didha Batu, Bonso Bude, Gebi Agero, Gudeta Hinika, Ismael Tura, Mohammed Kabeto, Abdella Amano Abdo, Desalegn Fikadu, Abashamo Lencho, Melik Tiba
Esophageal cancer disproportionately affects specific regions in Ethiopia, particularly the Arsi Bale areas. 1 , 2 Studies reveal that more than 50% of esophageal cancer cases in Ethiopia originate from Arsi-Bale region. 3 Collaborative efforts by individuals and institutions from this region-initiated actions to elevate esophageal cancer as a national concern. This abstract illustrates the collaborative process and the formation of the Esophageal Cancer Consortium in Ethiopia. The method encompasses collaborative discussions, real-time documentation during detailed dialogues, and iterative reviews aimed at capturing the program's evolution and key achievements. Experts from clinical and public health fields, actively involved throughout the program's lifecycle, contributed insights from its inception to its current state. Initiatives to prioritize esophageal cancer as a public health concern in Arsi-Bale regions were spearheaded by individuals and diasporas from these regions. These efforts led to the first conference at Arsi University in 2022, involving clinicians, researchers, public figures, and community leaders, along with four educational institutions, namely Arsi University, Madda Wallabu University, Adama Hospital Medical College, and Arsi Negelle General Hospital and Medical College, and International Oromo Health Professional Association (IOHPA). This conference resulted in forming the Southeast Esophageal Cancer Task Force (SEECTF). Progressive efforts, including regular weekly meetings under the structured SEECTF, led to the implementation of a first-of-its-kind endoscopy curriculum in Ethiopia, initiation of endoscopy diagnosis in previously unequipped hospitals, and the development of the first Esophageal cancer treatment guidelines and training manuals in Ethiopia. Community education pamphlets in local languages and community education through mass media were implemented. During the second national esophageal cancer conference in 2023, which led to national recognition, MOUs were signed with the Ministry of Health, Oromia Regional Health Bureau, the four educational institutions, and IOHPA. This conference resulted in the formation of a centralized consortium involving these institutions under one umbrella, working on research, advocacy, and capacity building, channeling esophageal cancer actions nationally. Collaborative efforts by individuals and institutions are crucial in influencing policymakers, addressing public health concerns, and garnering national attention and action to reduce the burden of esophageal cancer and enhance patients' quality of life in Ethiopia.
{"title":"Collaborative Action for Public Health: The Esophageal Cancer Consortium's Approach to Policy Influence and Capturing Policy Makers' Attention in Ethiopia","authors":"B. T. Deressa, Haji Aman Deybasso, Abebe Megerso, Jibril Bashir Adem, Dagim Tekeba, M. Mama, Didha Batu, Bonso Bude, Gebi Agero, Gudeta Hinika, Ismael Tura, Mohammed Kabeto, Abdella Amano Abdo, Desalegn Fikadu, Abashamo Lencho, Melik Tiba","doi":"10.1200/go-24-39000","DOIUrl":"https://doi.org/10.1200/go-24-39000","url":null,"abstract":"Esophageal cancer disproportionately affects specific regions in Ethiopia, particularly the Arsi Bale areas. 1 , 2 Studies reveal that more than 50% of esophageal cancer cases in Ethiopia originate from Arsi-Bale region. 3 Collaborative efforts by individuals and institutions from this region-initiated actions to elevate esophageal cancer as a national concern. This abstract illustrates the collaborative process and the formation of the Esophageal Cancer Consortium in Ethiopia. The method encompasses collaborative discussions, real-time documentation during detailed dialogues, and iterative reviews aimed at capturing the program's evolution and key achievements. Experts from clinical and public health fields, actively involved throughout the program's lifecycle, contributed insights from its inception to its current state. Initiatives to prioritize esophageal cancer as a public health concern in Arsi-Bale regions were spearheaded by individuals and diasporas from these regions. These efforts led to the first conference at Arsi University in 2022, involving clinicians, researchers, public figures, and community leaders, along with four educational institutions, namely Arsi University, Madda Wallabu University, Adama Hospital Medical College, and Arsi Negelle General Hospital and Medical College, and International Oromo Health Professional Association (IOHPA). This conference resulted in forming the Southeast Esophageal Cancer Task Force (SEECTF). Progressive efforts, including regular weekly meetings under the structured SEECTF, led to the implementation of a first-of-its-kind endoscopy curriculum in Ethiopia, initiation of endoscopy diagnosis in previously unequipped hospitals, and the development of the first Esophageal cancer treatment guidelines and training manuals in Ethiopia. Community education pamphlets in local languages and community education through mass media were implemented. During the second national esophageal cancer conference in 2023, which led to national recognition, MOUs were signed with the Ministry of Health, Oromia Regional Health Bureau, the four educational institutions, and IOHPA. This conference resulted in the formation of a centralized consortium involving these institutions under one umbrella, working on research, advocacy, and capacity building, channeling esophageal cancer actions nationally. Collaborative efforts by individuals and institutions are crucial in influencing policymakers, addressing public health concerns, and garnering national attention and action to reduce the burden of esophageal cancer and enhance patients' quality of life in Ethiopia.","PeriodicalId":14806,"journal":{"name":"JCO Global Oncology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}